Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the...
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the...
Performance Health is excited to announce the acquisition of Sissel France, a premier distributor of consumer and professional products in...
The Indian sports nutrition market is on the brink of a significant transformation with the strategic partnership between Nutra Prep,...